Tenders
Cardiovascular drug tenders in Estonia
Cardiovascular drug tenders in Estonia: 41 listed on GranTender since 2024; none is open now. The median awarded contract value is about €3,400 (361 contracts with a stated value). Buyers with the most tenders: Aktsiaselts Lääne-Tallinna Keskhaigla (11), Sihtasutus Pärnu Haigla (7) and Sihtasutus Ida-Viru Keskhaigla (6); suppliers with the most contract awards: Tamro Eesti OÜ (155), Magnum Medical OÜ (136) and Apteegikaubanduse Hulgimüük OÜ (56). Sources: Riigihangete register and TED. In 2025 the median contract value was €3,400; 48% of contracts drew a single bid (1.7 bids on average). Data as of 17 November 2026; updated daily.
- Tenders
- 41
- Open tenders
- 0
- Awards
- 412
- Awarded value awarded
- €27,556,786
- Awarded value contract
- €1,653,557
- Awarded value framework ceiling
- €2,777,590
- Median contract value awarded
- ≈ €3,400
- Median contract value framework ceiling
- ≈ €1,700
- Average bids per contract
- 1.5
- Tenders in 2025
- 12 -37% on 2024
Median: contracts with a stated value, rounded. Average bids: contracts where the number of bids is published.
Value kinds: awarded — the value in the award decision; contract — the value of the signed or amended contract; paid — the amount actually paid; framework ceiling — the maximum of a framework agreement, given with every winner, not money spent. Different kinds are never added together.
Open tenders
No records yet.
Latest tenders
Top buyers
Top winners
Competition and prices
In 2025, half of the contracts were worth between €1,000 and €12,000, with a median of €3,400 (102 contracts with a stated awarded value). Contracts drew 1.7 bids on average (median 2) and 48% drew a single bid — based on 103 contracts with a known number of bids. Compared with 2024, in 2025 the median value fell 66% and the share of single-bid contracts fell from 55% to 48%. The usual procedures: open procedure (93%), negotiation without a call for competition (8%) — of 40 tenders with a stated procedure.
The most contracts went to Tamro Eesti OÜ (155), Magnum Medical OÜ (136) and Apteegikaubanduse Hulgimüük OÜ (56) — together 84% of all contracts.
| Year | Contracts | Median value | Middle half of values | Bids on average | Single bid |
|---|---|---|---|---|---|
| 2024 | 124 | €10,000 | €2,300 – €41,000 | 1.5 | 55% (117) |
| 2025 | 104 | €3,400 | €1,000 – €12,000 | 1.7 | 48% (103) |
| 2026 (so far) | 161 | €1,800 | €580 – €12,000 | 1.2 | 81% (89) |
| All years | 412 | €3,400 | €870 – €16,000 | 1.5 | 59% (331) |
Values: contracts with a stated value in EUR, each value kind on its own (awarded or contract value), approximate (±3 %). Bids: contracts of procedures with competition whose number of bids the source publishes (1–100 bids); the sources publish it for some contracts only (TED ≈ 3 in 4, Spain all, Poland about half, Italy few), so each figure states its base and is shown from 20 contracts. A contract counts in the year of its award (else of its tender). Figures as of 13 November 2026, recomputed every week.
Where you have a chance
Since 1 November 2024, 63% of the 209 contracts with a known number of bids had a single bid; the median was 1 bid. The number of bids is known for 209 of the 281 contracts from procedures with competition.
Buyers who often get few offers
The buyers below usually received one or two offers per contract — an offer from you would stand out.
| Buyer | Contracts with known bids | Median bids | Single bid |
|---|---|---|---|
| Aktsiaselts Lääne-Tallinna Keskhaigla | 94 | 1 | 73% |
| Sihtasutus Pärnu Haigla | 36 | 2 | 36% |
| Sihtasutus Viljandi Haigla | 21 | 1 | 52% |
| Aktsiaselts Rakvere Haigla | 16 | 1 | 50% |
| Sihtasutus Ida-Viru Keskhaigla | 13 | 1 | 54% |
| sihtasutus Tartu Ülikooli Kliinikum | 9 | 1 | 100% |
In the last 12 months, 0 companies won their first contract in our records here — 0% of the 195 contracts (our records start on 1 January 2024).
Contracts awarded since 1 November 2024 (the last 24 months). Bids as the source publishes them, 1 to 100 per contract, in procedures with competition only (a direct award has one offer by design). As of 13 November 2026.
Main CPV divisions
CPV codes of this topic
A tender belongs here when its main CPV code starts with one of these codes; a tender without a usable CPV code (or with a general one) is matched by words of its title. A tender may belong to up to three topics.
Expected soon1
| Expected | Buyer | What | Why we expect it | Confidence |
|---|---|---|---|---|
| Apr – Sep 2027 | Aktsiaselts Lääne-Tallinna Keskhaigla | Cardiovascular and anticoagulant drugs | The current contract with TAMRO EESTI OÜ ends on 5 October 2027 (from its stated duration); no new tender has been published yet. | high |
Forecast from public data, not an announcement. Methodology.
Market reports
Cardiovascular and anticoagulant drugs by city
Cardiovascular and anticoagulant drugs in other countries
Cardiovascular and anticoagulant drugs across Europe
Topics in Health, medical equipment and medicines
Questions and answers
- Which cardiovascular drug tenders in Estonia are open now?
- None is open at the moment; GranTender lists 41 in total.
- Where can I find cardiovascular drug tenders in Estonia?
- GranTender lists them in one place, from Riigihangete register and TED, with their buyers, winners and contract values; 0 are open now. Search in one country at a time (the first 5 results) is free; search across all countries at once, full result lists, saved keywords with an e-mail once a week and exports come with a plan.
- Who wins the most cardiovascular drug tenders in Estonia?
- By number of contracts won: Tamro Eesti OÜ (155), Magnum Medical OÜ (136), Apteegikaubanduse Hulgimüük OÜ (56).
- Which buyers publish the most cardiovascular drug tenders in Estonia?
- By number of tenders: Aktsiaselts Lääne-Tallinna Keskhaigla (11), Sihtasutus Pärnu Haigla (7), Sihtasutus Ida-Viru Keskhaigla (6).
- Which CPV codes belong to “Cardiovascular and anticoagulant drugs”?
- 33620000 Medicinal products for the blood, blood-forming organs and the cardiovascular system; plus tenders without a usable CPV code whose title names the topic.
- How many bids do cardiovascular drug tenders in Estonia receive on average?
- In 2025, contracts drew 1.7 bids on average (median 2) and 48% drew a single bid — based on 103 contracts with a known number of bids.
- How much are contracts for cardiovascular drug tenders in Estonia worth?
- In 2025, half of the contracts were worth between €1,000 and €12,000, with a median of €3,400 (102 contracts with a stated awarded value). Compared with 2024, in 2025 the median value fell 66% and the share of single-bid contracts fell from 55% to 48%.
- Which procedures are used for cardiovascular drug tenders in Estonia?
- The usual procedures: open procedure (93%), negotiation without a call for competition (8%) — of 40 tenders with a stated procedure.
- Which buyers get few offers in cardiovascular drug tenders in Estonia?
- Since 1 November 2024, these buyers usually received one or two offers per contract: Aktsiaselts Lääne-Tallinna Keskhaigla (median 1 bid over 94 contracts), Sihtasutus Pärnu Haigla (median 2 bids over 36 contracts) and Sihtasutus Viljandi Haigla (median 1 bid over 21 contracts). Since 1 November 2024, 63% of the 209 contracts with a known number of bids had a single bid; the median was 1 bid.
CPV 2008 (Regulation (EC) No 213/2008), © European Union, Publications Office — via the eForms SDK, CC BY 4.0.